Medical Exoskeleton Market - Global Outlook & Forecast 2022-2027
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Medical Exoskeleton Market Report
The medical exoskeleton market by revenue is expected to grow at a CAGR of over 36% during the period 2022–2027.
Government is responsible for ensuring that exoskeleton products sold in its region are accepted and meet market requirements. As a result, the government has enacted appropriate legislation to ensure that goals are achieved, product safety is the primary objective, and that the sale of unsafe products does not harm citizens. However, if commercialization involves technical product developments, a technical, regulatory framework in which the appropriate regional authorities enact legislation applicable to all levels of government (national, state, state, local, etc.) covering product services and actions. Governments and regulators' safety is a major concern before new products are generally commercially available. In this regard, only a few exoskeletons such as ReWalk, Ekso Bionics, and Cyberdyne have been certified to comply with the evolving international safety guidelines in medical and non-medical applications essential for the market growth.
The following factors are likely to contribute to the growth of the medical exoskeleton market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook